Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.620 | ||
| Révision: | $699.00M | $807.60M | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | -0.120 | 0.600 | 0.7200 |
| Révision: | $718.74M | $776.00M | $3.26M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.500 | 0.460 | -0.0400 |
| Révision: | $788.00M | $748.90M | -$44.40M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.460 | 1.260 | 0.8000 |
| Révision: | $801.60M | $954.20M | $12.50M |
